At 2 Years, No CML Found in Half of Patients Who Stopped TKI Therapy

Cessation of tyrosine kinase inhibitor therapy may be possible in chronic myeloid leukemia patients with deep molecular response, according to the results of the Euro-Ski trial.

Source: CancerNetwork - December 4, 2016 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Conferences/ASH 2016 News Source Type: news